Finasteride
This Medication is for Use in Men Only
Finasteride, the Active Substance of Symasteride, is a 5-Alpha Reductase Inhibitor, an Enzyme that Converts Testosterone (Male Sex Hormone) into a More Potent Dihydrotestosterone (DHT). Symasteride Causes a Reduction in the Size of the Prostate Gland.
Symasteride is Used in a Condition Called Benign Prostatic Hyperplasia.
The Prostate Gland, Located in the Area of the Urinary Bladder, has Enlarged, Causing Difficulty in Urinating.
Symasteride is Indicated for the Treatment of Benign Prostatic Hyperplasia to:
If Your Sexual Partner is Pregnant or May Become Pregnant, You Should Avoid Exposing her to Your Semen, which may Contain Small Amounts of the Medication.
Symasteride is not Indicated for Use in Women.
Before Starting Treatment with Symasteride, Discuss it with Your Doctor.
Tell Your Doctor about all Your Current or Past Illnesses and Allergies.
Benign Prostatic Hyperplasia is a Condition that Develops Over Many Years, and it may Take Some Time to Notice Symptoms. Symasteride may Relieve Symptoms and Allow for Control of the Disease if Taken Regularly for a Long Time.
Symasteride is not Indicated for Use in Children.
Patients Taking Symasteride have Reported Mood Changes, such as Depressive Mood and Depression, and Rarely, Suicidal Thoughts. If You Experience any of these Symptoms, Seek Medical Advice Immediately.
Tell Your Doctor about all Medications You are Currently Taking or Plan to Take. Symasteride Usually Does not Affect the Action of Other Medications.
Symasteride can be Taken with or Without Food.
Women who are Pregnant or Breastfeeding, or Think They may be Pregnant, or are Planning to Have a Child, must not Take this Medication. They should also not Handle Crushed or Broken Symasteride Tablets.
If the Active Substance of the Medication Enters the Body (Orally or Through Skin Contact) of a Pregnant Woman, it may Cause Abnormalities in the Development of the Male Fetus's Genital Organs. If a Pregnant Woman is Exposed to the Active Substance of Symasteride, She should Inform Her Doctor. The Tablets are Coated to Prevent Direct Contact with the Active Substance, Provided that the Tablets are not Damaged or Crushed.
Your Doctor can Provide More Information on this.
There is no Evidence to Suggest that Finasteride Affects the Ability to Drive or Operate Machinery.
If You have been Diagnosed with an Intolerance to Some Sugars, Consult Your Doctor Before Taking the Medication.
The Medication Contains Less than 1 mmol (23 mg) of Sodium per Film-Coated Tablet, which means it is Essentially Sodium-Free.
This Medication should Always be Taken as Directed by Your Doctor. If You have any Questions, Ask Your Doctor.
The Recommended Dose is One 5 mg Tablet per Day, which can be Taken with or Without Food.
The Medication should be Taken Orally.
Remember that Benign Prostatic Hyperplasia is a Long-Term Condition, and it may Take Some Time to Notice Symptoms. Symasteride may Relieve Symptoms and Allow for Control of the Disease if Taken Regularly for a Long Time.
No Dose Adjustment is Required in Patients with Kidney or Liver Impairment.
No Dose Adjustment is Required in the Elderly.
If You Take More Tablets than Recommended, Contact Your Doctor Immediately.
Take Symasteride as Directed by Your Doctor. If You Miss a Dose, Do not Take an Extra Tablet. The Next Day, Continue with the Prescribed Dose.
If You have any Further Questions on the Use of this Medication, Ask Your Doctor or Pharmacist.
Like all Medications, Symasteride can Cause Side Effects, although not Everybody gets them.
Common(may affect up to 1 in 10 people):
In Some Cases, these Symptoms may Disappear During Treatment. However, if the Side Effects Persist, Consult Your Doctor, who may Decide to Stop the Treatment with Symasteride.
Uncommon(may affect up to 1 in 100 people):
Frequency Not Known(cannot be estimated from the available data):
Stop Taking the Medication and Contact Your Doctor Immediately if You Experience any of the Following Symptoms (Angioedema): Swelling of the Face, Lips, Tongue, or Throat, Difficulty Swallowing, Hives, and Difficulty Breathing.
If You Experience any Side Effects, including those not Listed in this Package Leaflet, Tell Your Doctor or Pharmacist. Side Effects can be Reported Directly to the Department of Medicinal Product Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Side Effects can also be Reported to the Marketing Authorization Holder.
Reporting Side Effects will Help to Gather More Information on the Safety of this Medication.
Keep the Medication out of Sight and Reach of Children.
There are no Special Requirements for Storing the Medication.
Do not Use this Medication after the Expiration Date Stated on the Carton after EXP. The Expiration Date refers to the Last Day of the Month Stated.
Do not Throw Away Medications via Wastewater or Household Waste. Ask Your Pharmacist how to Dispose of Medications that are no Longer Needed. This will Help Protect the Environment.
The Active Substance is Finasteride.
Each Film-Coated Tablet Contains 5 mg of Finasteride.
The Other Ingredients are:
Tablet Core:
Lactose Monohydrate, Microcrystalline Cellulose, Maize Starch, Lauryl Macrogolglycerides, Sodium Carboxymethylcellulose (Type A), Magnesium Stearate.
Coating:
Hypromellose 6cps, Titanium Dioxide (E171), Indigo Carmine (E132), Lacquer, Macrogol 6000.
Symasteride Film-Coated Tablets are Blue, Round, 7 mm in Diameter, and Marked with "F5" on one Side.
Package Sizes:
Aluminium/PVC Blister Pack in a Carton:
7, 10, 14, 15, 20, 28, 30, 50, 60, 90, 98, 100 Film-Coated Tablets.
28x1, 30x1, 50x1, 98x1, 100x1 Film-Coated Tablets in a Divisible Blister Pack.
HDPE Bottle with LDPE Cap:
100, 250, 500 Film-Coated Tablets.
Not all Package Sizes may be Marketed.
Farmak International Sp. z o.o.
ul. Koszykowa 65
00-667 Warsaw
Zentiva k.s
U Kabelovny 130, 102 37 Praha 10, Czech Republic
Farmak International Sp. z o.o., ul. Chełmżyńska 249, 04-458 Warsaw
Poland:
Symasteride
Date of Last Revision of the Package Leaflet:May 2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.